MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Alert me to new issues of the journal
Development of a Novel Nitro-Derivative of Noscapine for the Potential Treatment of Drug-Resistant Ovarian Cancer and T-Cell Lymphoma
Mol Pharmacol Aneja et al. 69: 1801

Erratum

Correction to “Development of a Novel Nitro-Derivative of Noscapine for the Potential Treatment of Drug-Resistant Ovarian Cancer and T-Cell Lymphoma”

In the above article Aneja R, Vangapandu SN, Lopus M, Chandra R, Dulal P, and Joshi HC (2006) Mol Pharmacol 69:1801–1809, there was an error in Fig. 4 on page 1807. One of the published panels was from an experiment different from that described in the figure legend. The corrected version of Fig. 4 appears online only. The figure legend has not been changed.

The online version has been corrected in departure from the print version.

The authors regret this error and apologize for any confusion or inconvenience it may have caused.





This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Submit a response
Services
Right arrow Alert me to new issues of the journal

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics